Drugs / CEFACLOR ANHYDROUS
CEFACLOR ANHYDROUS
also known as
Cefaclor · Bacticlor mr · Ceclor · Ceclor cd · Cefaclor monohydrate · Cefaclor/Ceclor · COMPOUND 99638 · Distaclor · +5 more
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | CECLOR | — | 1979-04-04 | fda.gov ↗ |
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06406114 | May 2025 → Jul 2028 expected | anaphylaxis, drug allergy, drug pseudoallergy | Massachusetts General Hospital | Recruiting | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT02490293 | Jun 2015 → Jun 2016 | acute cholecystitis | Taeho Hong | Completed | No outcome recorded |
| — | NCT01561703 | Mar 2012 → Dec 2013 | streptococcal sore throat | University of Missouri-Columbia | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT06640439 Background | Oct 2024 → Feb 2025 overdue | impacted teeth, multiple | Huashan Hospital | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT02099240 Comparator | Mar 2014 → Nov 2018 | osteomyelitis | University of Louisville | Terminated | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05398679 Comparator | Aug 2022 → Dec 2026 expected | infective endocarditis | Fundacion Clinic per a la Recerca Biomédica | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05925309 Comparator | Jul 2023 → Dec 2027 expected | biliary atresia, cholangitis | Children's Hospital of Fudan University | Recruiting | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2002-09-05 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Announces Approval of Cefaclor ER Tablets tevapharm.com ↗ |
Evidence & citations 16 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CEFACLOR ANHYDROUS | ChEMBL registry synonym — accepted as the source's own label CHEMBL680 ↗ |
| Known as | Bacticlor mr | ChEMBL registry synonym — accepted as the source's own label CHEMBL680 ↗ |
| Known as | Ceclor | ChEMBL registry synonym — accepted as the source's own label CHEMBL680 ↗ |
| Known as | Ceclor cd | ChEMBL registry synonym — accepted as the source's own label CHEMBL680 ↗ |
| Known as | Cefaclor | “One of seven antibiotics (amoxicillin; amoxicillin/clavulanate potassium; azithromycin; cefaclor; cephalexin; cefdinir; or clindamycin) will be given at standard dosage” NCT01561703 ↗6“After discharge, oral intakes of 500mg each (1 pill of cefaclor, the 2nd generation cephalosporin every 12 hrs) for three days.” NCT02490293 ↗ “ibuprofen 0.3 g bid for 3 days, metronidazole 0.1 g tid, and cefaclor 0.375 g bid for 7 days after surgery” NCT06640439 ↗ “Cefaclor” NCT02099240 ↗ |
| Known as | Cefaclor monohydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL680 ↗ |
| Known as | Cefaclor/Ceclor | “Cefaclor/Ceclor” NCT01561703 ↗ |
| Known as | COMPOUND 99638 | ChEMBL registry synonym — accepted as the source's own label CHEMBL680 ↗ |
| Known as | Distaclor | ChEMBL registry synonym — accepted as the source's own label CHEMBL680 ↗ |
| Known as | Distaclor mr | ChEMBL registry synonym — accepted as the source's own label CHEMBL680 ↗ |
| Known as | J01DC04 | ChEMBL registry synonym — accepted as the source's own label CHEMBL680 ↗ |
| Known as | Keftid | ChEMBL registry synonym — accepted as the source's own label CHEMBL680 ↗ |
| Known as | NSC-757422 | ChEMBL registry synonym — accepted as the source's own label CHEMBL680 ↗ |
| Known as | Raniclor | ChEMBL registry synonym — accepted as the source's own label CHEMBL680 ↗ |
| Modality | Small molecule | — CHEMBL680 ↗ |
| Route | Oral | “After discharge, oral intakes of 500mg each (1 pill of cefaclor, the 2nd generation cephalosporin every 12 hrs) for three days.” NCT02490293 ↗ |